March 12, 2025 · Form 4 insider transaction
Aebersold Sarah sold 7,324 shares of BioLife Solutions, Inc. at $26.34 per share, a transaction worth $192.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024.